Richard A. Larson to Blood Glucose
This is a "connection" page, showing publications Richard A. Larson has written about Blood Glucose.
Connection Strength
0.025
-
Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial. Leukemia. 2016 05; 30(5):1044-54.
Score: 0.025